Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06111365 · ClinicalTrials.gov registry record
Pivotal Observational CHLOE Study
A clinical trial of IVF, sponsored by Fairtility.
- Completed
- Registry status
- 59
- Enrollment target
- 3
- Study locations
NCT06111365 is a study of IVF that has completed, run by Fairtility. The registered enrollment target is 59 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT06111365, a study of IVF, has completed, sponsored by Fairtility.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 3
- Study locations
Study Summary
This pivotal study is an observational, prospective assessment, multi-center, databank based, clinical study aimed to evaluate the performance of CHLOE™ algorithm in prediction of blastocyst formation.
Conditions Studied
Interventions
- DEVICE CHLOE
Study Locations (3)
New York
- Weill Cornell Medicine - New York
Ohio
- Cleveland Clinic Fertility - Cleveland
Texas
- Dallas Fertility Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-08-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06111365
The ClinicalTrials.gov registry entry for NCT06111365 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fairtility, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with IVF appearing as the primary indexed condition, and to 1 intervention - of which CHLOE is the first listed.
NCT06111365 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New York, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT06111365 about?
NCT06111365 is a clinical study titled "Pivotal Observational CHLOE Study". This pivotal study is an observational, prospective assessment, multi-center, databank based, clinical study aimed to evaluate the performance of CHLOE™ algorithm in prediction of blastocyst formation.
What is the current status of trial NCT06111365?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2024-01-22. Estimated completion is 2024-08-12.
What conditions does trial NCT06111365 study?
This clinical trial studies the following conditions: IVF.
What interventions are being tested in trial NCT06111365?
The interventions under investigation include: CHLOE (DEVICE).
Who is sponsoring clinical trial NCT06111365?
This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06111365 being conducted?
This trial has 3 study locations across New York, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IVF
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.